Stock Movers
iHeartPodcasts
Listen for five-minute conversations on today's biggest winners and losers in the stock market.
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.
Episodes
Mentioned books
4 snips
Mar 26, 2026 • 4min
H&M Sales Fall Short of Expectations; Pony AI Swings to Profit; Henkel to Buy Hair-Care Brand Olaplex
A roundup of market movers, from H&M’s underwhelming Q1 sales and inventory concerns to Pony AI reporting its first profitable quarter thanks to investment gains. A major beauty deal as Henkel agrees to buy Olaplex for $1.4 billion. Also coverage of chip stock weakness after fresh tech demand worries.
Mar 26, 2026 • 4min
Boliden Slumps, Next Gains, Aviva Drops
Tiwa Adebayo, Bloomberg market reporter covering miners, retailers and insurers. She breaks down Boliden’s production hit at Garpenberg and its market fallout. She explains Next’s profit tweak and the £15m Middle East cost risk. She highlights insurer worries after Jefferies’ private credit losses and the pressure on names like Aviva.
Mar 25, 2026 • 3min
Arm Surges, Driven Brands Rises, Navan Strong Earnings
A tech shakeup as Arm reveals plans to sell its own high-core AGI CPU and projects massive revenue. A corporate drama unfolds with pressure on Driven Brands to consider a sale or breakup. Travel software Navan spikes after a stronger-than-expected quarterly report and investor interest.
Mar 25, 2026 • 8min
Closing Bell: Arm Soars, JetBlue Surges, Energy and Chemical Stocks Fall
A tech blitz around Arm selling its own AGI CPU and landing Meta as a launch customer. Airline drama as JetBlue weighs selling itself and exploring tie-ups with major carriers. Energy and chemical stocks tumble amid geopolitical headlines about Iran. Plus a quick look at SpaceX IPO buzz and leadership shakeups rippling through markets.
Mar 25, 2026 • 6min
JetBlue Soars, Meta Gains, Arm Rises
Talks about JetBlue weighing a potential sale and which major carriers might be involved. Covers Meta cutting several hundred roles amid a wider reorganization and AI spending shift. Explores Arm’s strategic move from licensing to selling its own chips and the market reaction to that plan.
Mar 25, 2026 • 2min
KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips
Avalon Pernell, Bloomberg reporter and market commentator who gives concise rundowns of company moves. She breaks down Arm’s plan to sell its own AI chips and the Meta tie-up. She covers KB Home missing delivery forecasts and the market reaction. She also outlines Merck’s takeover of Terns and what moved biotech stocks.
Mar 25, 2026 • 3min
ARM Rises, Chewy Gains, Echostar Up on Report SpaceX to File for IPO Soon as This Week
Chipmaker news about a new high-core AGI CPU and a big deal with a major tech company sparks market buzz. An online pet retailer lifts its multi-year sales forecast, signaling strong consumer demand. Satellite and space-related stocks jump on reports of a major space company preparing an IPO filing.
Mar 25, 2026 • 5min
Merck to Buy Terns; Pentagon Inks Deals to Boost Production; Chewy Shares Gain
A major pharma takeover for a promising leukemia therapy and the patent pressures driving big deal-making. Defense agreements aim to speed up missile seeker production and surge munitions manufacturing. An online pet retailer posts a sales forecast that sends its shares higher.
Mar 25, 2026 • 4min
Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb
A corporate takeover makes waves with a big biotech buyout. A chip-IP giant pivots to selling its own processors and aims for huge data-center revenue. A software company beats sales expectations and rolls out AI-driven products. Industrywide chip shortages and price hikes loom over the tech sector.
Mar 24, 2026 • 4min
KB Homes Down, Arm to Sell Its Own Chips, ImmunityBio Plunges
Avalon Purnell, Bloomberg equities reporter who breaks down movers in the market. She covers KB Home missing Q2 delivery forecasts and investor reaction. She explains Arm’s shift to selling its own chips and the ambitious $15 billion target. She reviews ImmunityBio’s stock plunge after an FDA warning letter.
